Cormica Ltd is a privately held contract testing organisation registered in England and Wales (Company No. 13507942), headquartered at 12–18 Grosvenor Gardens, 5th Floor, London SW1W 0DH, with its primary laboratory operations telephone line at 0330 174 0668. The company operates six laboratory sites across the United Kingdom, Europe, and the United States, and is a member of a broader group that includes Astoriom and Concept Life Sciences as strategic partners.

The company’s operational heritage spans over six decades, incorporating several established testing laboratories through a group structure that encompasses Wickham Micro (UK), Medical Engineering Technologies UK, Cormica Bradford, Zwisler Laboratorium (EU), Focus Laboratories, and TPM Labs. This multi-site network provides geographically distributed accredited testing capacity across key regulated markets, with accreditations from UKAS (ISO 17025), FDA, and MHRA, and compliance with EU MDR requirements.

Cormica’s client base spans pharmaceutical manufacturers (including a top-five Indian pharmaceutical company among named clients), medical device manufacturers, combination product developers, and compounding pharmacies. Named client organisations include Kimal, Gerresheimer Bünde GmbH, Prosys International, and Ostique. In 2026, Cormica appointed a dedicated Business Development Manager for North America, reflecting an active commercial expansion effort in the US market, and recently opened a medical device chemistry laboratory at its Bradford Centre of Excellence.

Key Products and Services

Analytical Chemistry Testing

• Method development, validation, and transfer — development and validation of analytical methods to ICH and pharmacopoeial standards; method transfer between laboratories or from client to Cormica
• QC batch release testing — pharmaceutical and medical device product release testing against registered specifications
• ICH stability studies — accelerated and long-term stability testing under ICH Q1A(R2) climate conditions; real-time ageing programmes
• Extractables and leachables (E&L) — extractables screening and leachables studies for pharmaceutical primary packaging, medical devices, inhalers, and combination products; compliant with ISO 10993-18 and USP guidance
• Impurity analysis services — identification, quantification, and characterisation of process- and degradation-related impurities; nitrosamines and polymorphic impurity testing
• Particle and powder properties characterisation — particle size distribution, powder flow, density, and morphological analysis using laser diffraction (Mastersizer 3000 and equivalent)
• Cleaning validation and verification — residue analysis and swab testing for pharmaceutical and medical device cleaning validation programmes
• ANDA services for generic pharmaceuticals — full analytical support for ANDA submissions, including method development, comparative dissolution profiling, and physicochemical characterisation
• Formulation development — analytical support for pharmaceutical formulation development programmes
• Solid form optimisation — polymorph screening, salt selection, and solid form characterisation

Microbiology Testing

• Microbiological QC testing — total viable count, yeasts and moulds, specific organism testing, and environmental isolate identification
• Sterility testing — Ph. Eur. and USP-compliant sterility testing for pharmaceutical products and medical devices
• Environmental monitoring — cleanroom microbiological environmental monitoring programmes
• Bacterial endotoxin testing (BET) — LAL and recombinant Factor C (rFC) methods for endotoxin detection
• Bioburden testing — bioburden determination for medical devices and pharmaceutical products
• Antimicrobial efficacy testing — preservative efficacy testing (PET) and disinfectant efficacy testing to European and US standards
• Microbial identification — MALDI-ToF-based rapid microbial identification of environmental and product isolates
• Reprocessing validation — validation of reprocessing (cleaning, disinfection, sterilisation) procedures for reusable medical devices

Physical and Functional Testing

• Design verification and validation testing — mechanical, dimensional, and functional testing to support medical device design verification and validation (V&V)
• Needle-based injection systems (ISO 11608) — glide force, activation force, needle penetration, and other performance tests for injector devices and pen injectors
• Pre-filled syringe testing (ISO 11040) — physical, functional, and extractables testing for pre-filled syringe systems
• Auto-injector testing — activation force, needle retraction, delivery volume, and human factors-related functional testing
• Catheters, infusion sets, and connectors (ISO 80369) — physical and functional performance testing for small bore connectors and fluid pathway devices
• On-body injector and wearable device testing — functional and performance testing for wearable drug delivery devices
• Intraocular lens (IOL) testing — optical, mechanical, and dimensional characterisation of IOLs
• Cardiovascular, orthopaedic, dental, ophthalmic, and robotic surgery device testing — indication-specific functional and mechanical testing across a broad range of device categories
• Anaesthesia and respiratory device testing

Packaging Testing

• Packaging validation (ISO 11607) — validation of sterile barrier systems for medical devices and pharmaceutical products
• Container closure integrity testing (CCIT) — headspace gas analysis, vacuum decay, and dye ingress methods for container closure integrity of sterile pharmaceutical packaging
• Accelerated and real-time ageing — temperature and humidity-accelerated ageing studies for shelf-life determination
• Transit and distribution testing — ISTA and ASTM-compliant transit simulation testing for pharmaceutical and medical device packaging

Biocompatibility and Regulatory Support

• ISO 10993 biocompatibility testing — cytotoxicity, sensitisation, irritation, genotoxicity, pyrogenicity, and haemocompatibility testing to ISO 10993 series and ISO 18562 (breathable gas pathway devices)
• Biological Evaluation Plans (BEP) and Biological Evaluation Reports (BER) — consultancy and authoring services for EU MDR-compliant biological safety evaluation documentation
• Clinical Evaluation Plans (CEP) and Clinical Evaluation Reports (CER) — regulatory consultancy and authoring support for EU MDR CER requirements
• Inhaler and orally inhaled and nasal drug product (OINDP) testing — specialist testing for metered dose inhalers, dry powder inhalers, and nasal products

Cormica occupies a well-established position in the UK and European contract testing landscape as a multi-site, multi-disciplinary laboratory group combining pharmaceutical analytical testing, medical device functional and biocompatibility testing, and microbiology testing under a single accredited organisation. Its six-decade heritage — consolidated through the integration of several established specialist laboratories including Wickham Micro, Zwisler Laboratorium, and Medical Engineering Technologies UK — provides both a depth of institutional expertise and a breadth of technical capability that a single-site laboratory or a newly established testing CRO cannot match. The combination of GMP, GLP, and ISO 17025 (UKAS) accreditation across multiple sites is a practical differentiator for pharmaceutical and medical device clients whose regulatory submissions require laboratory data generated under multiple quality frameworks simultaneously. The recent appointment of a North America Business Development Manager and the opening of the Bradford medical device chemistry laboratory signal active investment in geographic and capability expansion.